Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-07-19
2005-07-19
Rao, Deepak (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S327000
Reexamination Certificate
active
06919342
ABSTRACT:
The invention relates to triazole compounds of the general formula IwhereinR1is hydrogen or methyl, andR2is C3-C4alkyl or C1-C2fluoroalkyl,as well as the physiologically tolerated acid addition salts of these compounds.The invention also relates to a pharmaceutical composition that comprises at least one triazole compound of the formula I and/or at least one physiologically tolerated acid addition salt thereof, and further to a method for treating disorders that respond beneficially to dopamine D3receptor antagonists or dopamine D3agonists, said method comprising administering an effective amount of at least one triazole compound or physiologically tolerated acid addition salt of the formula I to a subject in need thereof.
REFERENCES:
patent: WO 96/02520 (1996-02-01), None
patent: WO 99/02503 (1999-01-01), None
patent: WO 00/42036 (2000-07-01), None
patent: WO 00/42037 (2000-07-01), None
patent: WO 00/42038 (2000-07-01), None
Poirier, PubMed Abstract (Press Med. 27(40):2185-9), Dec. 1998.
Levant, The D3 Dopamine Receptor: Neurobiology and Potential Clinical Relevance, Pharmacological Reviews, vol. 49, No. 3, pp. 231-252, 1997.
Sokoloff, et al., Molecular Cloning and characterization of a novel dopamine receptor (D3) as a target for neuoleptics, Nature 1990, pp. 146-151, vol. 347, France.
Schwartz, et al., The Dopamine D3 Receptor as a Target for Antipsychotics, in Meltzer, H.Y. (Ed) Novel Antipsychotic Drugs, 1992, pp. 135-144; New York.
Sokoloff, et al., Localization and Function of the D3Dopamine Receptor, Drug. Res. 1992; pp. 224-230; vol. 42(I) 2a; France.
Joyce, J. N., Dopamine D3 receptor as a therapeutic target for antipsychotic and antiparkinsonion drugs; Pharmacology & Therapeutics, 2001; pp. 231-259; vol. 90; Arizona.
Dooley, M., et al., Pramipexole, Drugs and Aging; 1998; pp. 495-514, vol. 12(6); New Zealand.
Braje Wilfried
Drescher Karla
Geneste Hervé
Grandel Roland
Haupt Andreas
Abbott & GmbH & Co. KG
Rao Deepak
Wood Phillips Katz Clark & Mortimer
LandOfFree
Triazole compounds suitable for treating disorders that... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Triazole compounds suitable for treating disorders that..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Triazole compounds suitable for treating disorders that... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3407410